Kerendia 10 mg Tablet is primarily indicated for adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D). This medicine falls under a class known as cardiovascular and renal protective agents.
This tablet also helps reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalisation for heart failure.
Before starting this tablet, consult your doctor to determine the appropriate dosage and frequency for your condition. It is crucial to inform your doctor about any pre-existing conditions, current medications, or supplements you are taking. If you experience side effects, report them promptly to your healthcare provider.